Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole for healing and maintenance of erosive esophagitis in adolescents
NCT01642615Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of dexlansoprazole in erosive esophagitis (EE), gastroesophageal reflux disease (GERD), sponsored by Takeda. Started Jul 2012; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
erosive esophagitis (EE)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01642615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642615.